BI
RLAY icon

BVF Inc’s Relay Therapeutics RLAY Stock Holding History

BVF Inc’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,970,045
Closed -$43.7M – 67
2023
Q4 		$43.7M Buy
3,970,045
+1,604,240
+68% +$13.5M 1.09% 24
2023
Q3 		$19.9M Sell
2,365,805
-754,716
-24% -$8.12M 0.54% 35
2023
Q2 		$39.2M Hold
3,120,521
– – 1.09% 25
2023
Q1 		$51.4M Sell
3,120,521
-755,500
-19% -$13.5M 1.88% 18
2022
Q4 		$57.9M Sell
3,876,021
-463,500
-11% -$8.87M 2.44% 11
2022
Q3 		$97.1M Sell
4,339,521
-45,284
-1% -$994K 4.01% 6
2022
Q2 		$73.4M Sell
4,384,805
-145,800
-3% -$3.12M 3.55% 9
2022
Q1 		$136M Buy
4,530,605
+1,400,000
+45% +$34M 5.42% 3
2021
Q4 		$96.1M Buy
3,130,605
+1,081,492
+53% +$34.2M 3.49% 8
2021
Q3 		$64.6M Sell
2,049,113
-889,089
-30% -$29.9M 2.52% 12
2021
Q2 		$108M Buy
2,938,202
+65,055
+2% +$2.14M 4.03% 9
2021
Q1 		$99.3M Sell
2,873,147
-200,000
-7% -$8.68M 3.72% 9
2020
Q4 		$128M Sell
3,073,147
-305,233
-9% -$13.8M 5.02% 4
2020
Q3 		$144M Buy
+3,378,380
New +$129M 7.84% 1

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

BVF Inc's RLAY Position: Q1 2024 in Review

BVF Inc sold out of Relay Therapeutics (RLAY) in Q1 2024, closing a stake of 3,970,045 shares — an estimated $43.7M sold.

BVF Inc first reported a position in RLAY in Q3 2020 and held it in 14 quarters. The position peaked at $144M in Q3 2020. 189 funds tracked by Wall St. Rank hold RLAY as of Q1 2024.

  • BVF Inc reported no remaining Relay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • BVF Inc sold 3,970,045 Relay Therapeutics shares in Q1 2024, an estimated $43.7M.
  • BVF Inc first reported a position in Relay Therapeutics in Q3 2020 and held it in 14 quarters.
  • BVF Inc's Relay Therapeutics position peaked at $144M in Q3 2020.
  • 189 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2024.

Based on BVF Inc's 13F filing for Q1 2024, filed 15 May 2024.